pI: 6.134 |
Length (AA): 455 |
MW (Da): 49908 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128995)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G24710 | P-loop containing nucleoside triphosphate hydrolases superfamily protein |
Brugia malayi | Bm1_18485 | ATPase, AAA family protein |
Caenorhabditis elegans | CELE_F10B5.5 | Protein PCH-2 |
Cryptosporidium hominis | Chro.60073 | thyroid receptor interacting protein 13 (TRIP-13) |
Cryptosporidium hominis | Chro.60074 | protein-related binding protein |
Cryptosporidium parvum | cgd6_550 | Pch2p like AAA ATpase |
Dictyostelium discoideum | DDB_G0279111 | AAA ATPase domain-containing protein |
Drosophila melanogaster | Dmel_CG31453 | CG31453 gene product from transcript CG31453-RB |
Echinococcus granulosus | EgrG_000823600 | pachytene checkpoint protein 2 |
Echinococcus multilocularis | EmuJ_000823600 | pachytene checkpoint protein 2 |
Giardia lamblia | GL50803_8524 | Transitional endoplasmic reticulum ATPase |
Homo sapiens | ENSG00000071539 | thyroid hormone receptor interactor 13 |
Leishmania braziliensis | LbrM.28.1960 | ATPase-like protein |
Leishmania donovani | LdBPK_281910.1 | ATPase-like protein |
Leishmania infantum | LinJ.28.1910 | ATPase-like protein |
Leishmania major | LmjF.28.1790 | ATPase-like protein |
Leishmania mexicana | LmxM.28.1790 | ATPase-like protein |
Loa Loa (eye worm) | LOAG_11130 | hypothetical protein |
Mus musculus | ENSMUSG00000021569 | thyroid hormone receptor interactor 13 |
Neospora caninum | NCLIV_040990 | Cell division cycle protein, related |
Oryza sativa | 4336167 | Os04g0479000 |
Plasmodium berghei | PBANKA_0909500 | AAA family ATPase, putative |
Plasmodium falciparum | PF3D7_1139500 | AAA family ATPase, putative, unspecified product |
Plasmodium knowlesi | PKNH_0937400 | AAA family ATPase, putative |
Plasmodium vivax | PVX_092575 | AAA family ATPase, putative |
Plasmodium yoelii | PY02067 | ATPase, AAA family, putative |
Saccharomyces cerevisiae | YBR186W | Pch2p |
Schistosoma japonicum | Sjp_0028260 | ko:K01516 nucleoside-triphosphatase [EC3.6.1.15], putative |
Schistosoma mansoni | Smp_171260 | thyroid hormone receptor interactor |
Schmidtea mediterranea | mk4.000527.02 | Pachytene checkpoint protein 2 homolog |
Trypanosoma brucei gambiense | Tbg972.11.10240 | ATPase-like protein, putative |
Trypanosoma brucei | Tb927.11.9160 | ATPase-like protein, putative |
Trypanosoma congolense | TcIL3000.11.9520 | ATPase-like protein, putative |
Trypanosoma cruzi | TcCLB.510901.90 | ATPase protein, putative |
Toxoplasma gondii | TGME49_288520 | ATPase, AAA family protein |
Trichomonas vaginalis | TVAG_077100 | spermatogenesis associated factor, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.0900 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.0900 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.0900 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.0900 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F10B5.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_0909500 | Plasmodium berghei | Dispensable | plasmo |
TGME49_288520 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.